A carregar...

Dosing of Erythropoiesis-Stimulating Agents Can Be Reduced by a New Administration Regimen

BACKGROUND/AIMS: At our hemodialysis (HD) unit, we noted a drop in the treatment dose of erythropoietin-stimulating agents (ESAs) when the frequency of dose adjustment was reduced from weekly, where doses were withheld if hemoglobin was >130 g/l, to monthly, where doses were not withheld. The aim...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Stefánsson, Bergur V., Haraldsson, Börje, Nilsson, Ulf
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290861/
https://ncbi.nlm.nih.gov/pubmed/22470378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000329889
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!